Outsmart The Market With These 3 AI Picks-And-Shovels Stocks
Every emerging sector has its picks-and-shovels stocks that represent the crucial tools and equipment necessary to take advantage of opportunities. Gold prospectors required picks and…
Zenect Wealth
In Bear Markets, Buy What’s Working
Cheap stocks can always get cheaper, particularly when the market direction is bearish. Which is why I don’t “dumpster dive” when I invest and why…
Top Steel Distributor For Value AND Growth
I was impressed every time I entered the BMW manufacturing facility in South Carolina. The speed of the line… The integration of robots with humans……
Best Semiconductor Stocks To Buy Right Now? 5 To Watch
Here Are Five Top Semiconductor Stocks To Watch Now. It’s not a surprise the semiconductor industry has been struggling in the stock market this year.…
Strong U.S. Dollar: Yet Another Recession Warning
Markets forecast recessions. Stock market weakness signals economic weakness. So does a decline in long-term interest rates in the bond market. The U.S. dollar is…
Best Cheap Stocks To Buy Now? 5 Consumer Discretionary Stocks To Watch
Among the headlines recently, U.S. inflation data dominated the scene as the consumer price index soared by 9.1% compared to the prior year. This will…
COVID-19 Vaccine Stocks: Is Inovio Still In Play?
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising pInovio Pharmaceuticals went from being…
All Psyched Up: A Current List Of Psychedelics Stocks To Watch
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising potential of psychedelic medicine drug…
2 Former Wall Street Pros Share Their 5 Innovative Stocks To Buy
At the recent Global Financial Summit, two former Wall Street professionals shared their picks for innovative stocks to buy for the opportunity to profit from…
When It Comes To These 2 Biopharma Stocks’ Near-Term Gains, Analysts Are Seeing (More Than) Double!
Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…